Sandostatin LAR Octreotide Injection

Sandostatin Details Brand Name: Sandostatin LAR Injection Contents: octreotide acetate Strengths: 20 mg Form: Injection Manufactured By: Novartis pharma stein AG, Switzerland Uses Octreotide is used to reduce the amount of growth hormone in patients with acromegaly (abnormal growth of hands, feet, and face, caused by overproduction of growth hormone) inadequately controlled by surgery or radiotherapy, or in patients not fit or unwilling for radiotherapy. It is also used to treat symptoms associated with functional gastro-entero-pancreatic (GEP) endocrine tumors. It is used to prevent complications following pancreatic surgery (risk of complications such as abscess in the abdomen, inflammation of the pancreas gland). In patients with cirrhosis (chronic liver disease), octreotide is used to stop bleeding and to protect from re-bleeding due to gastro-esophageal varices. It is also used to treat pituitary tumors that produce too much thyroid-stimulating hormone (TSH). How it works Octreotide belongs to class of medications called somatostatin analogue. Octreotide inhibits pathologically increased secretion of some natural chemicals in the body such as growth hormone, peptides and serotonin produced within the gastro-entero-pancreatic endocrine (GEP) system. Common side effects Nausea, Rash, Abdominal bloating, Abdominal pain, Biliary sludge (solids precipitated from bile), Bradycardia, Gall bladder inflammation, Bile duct stone, Constipation, Decreased thyroid stimulating hormone, Diarrhoea, Discolouration of stool, Dizziness, Shortness of breath, Fall in blood sugar level, Flatulence, Glucose intolerance, Hair loss, Headache, Increased bilirubin in the blood, Increased glucose level in blood, Indigestion, Injection site pain, Itching, Loss of appetite, Sticky stools, Vomiting, Weakness For Fast Reply please whatsapp : +919810566442